These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9421463

  • 1. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).
    Gutierrez-Steil C, Wrone-Smith T, Sun X, Krueger JG, Coven T, Nickoloff BJ.
    J Clin Invest; 1998 Jan 01; 101(1):33-9. PubMed ID: 9421463
    [Abstract] [Full Text] [Related]

  • 2. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes.
    Leverkus M, Yaar M, Gilchrest BA.
    Exp Cell Res; 1997 May 01; 232(2):255-62. PubMed ID: 9168800
    [Abstract] [Full Text] [Related]

  • 3. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L.
    Aragane Y, Kulms D, Metze D, Wilkes G, Pöppelmann B, Luger TA, Schwarz T.
    J Cell Biol; 1998 Jan 12; 140(1):171-82. PubMed ID: 9425165
    [Abstract] [Full Text] [Related]

  • 4. Regression of basal cell carcinoma by intralesional interferon-alpha treatment is mediated by CD95 (Apo-1/Fas)-CD95 ligand-induced suicide.
    Buechner SA, Wernli M, Harr T, Hahn S, Itin P, Erb P.
    J Clin Invest; 1997 Dec 01; 100(11):2691-6. PubMed ID: 9389732
    [Abstract] [Full Text] [Related]

  • 5. Role of apoptosis stimulus factor and its ligand in the induction of apoptosis in some ultraviolet induced diseases.
    Shaker O, Youssef R.
    Dermatol Online J; 2006 Mar 30; 12(3):4. PubMed ID: 16638418
    [Abstract] [Full Text] [Related]

  • 6. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy.
    Yamamoto T, Nishioka K.
    Skin Pharmacol Appl Skin Physiol; 2003 Mar 30; 16(1):50-8. PubMed ID: 12566829
    [Abstract] [Full Text] [Related]

  • 7. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
    Ehl S, Hoffmann-Rohrer U, Nagata S, Hengartner H, Zinkernagel R.
    J Immunol; 1996 Apr 01; 156(7):2357-60. PubMed ID: 8786290
    [Abstract] [Full Text] [Related]

  • 8. Loss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesis.
    Ouhtit A, Gorny A, Muller HK, Hill LL, Owen-Schaub L, Ananthaswamy HN.
    Am J Pathol; 2000 Dec 01; 157(6):1975-81. PubMed ID: 11106570
    [Abstract] [Full Text] [Related]

  • 9. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R, Reap EA, Cohen PL.
    J Immunol; 1998 Jul 01; 161(1):241-51. PubMed ID: 9647230
    [Abstract] [Full Text] [Related]

  • 10. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 01; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 11. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G, Smirne C, Carbone A, Mareschi K, Dughera L, Farina EC, Alabiso O, Valente G, Emanuelli G, Rodeck U.
    Clin Cancer Res; 2000 Jun 01; 6(6):2448-55. PubMed ID: 10873098
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
    Bernassola F, Scheuerpflug C, Herr I, Krammer PH, Debatin KM, Melino G.
    Cell Death Differ; 1999 Jul 01; 6(7):652-60. PubMed ID: 10453076
    [Abstract] [Full Text] [Related]

  • 13. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
    Filipowicz E, Adegboyega P, Sanchez RL, Gatalica Z.
    Cancer; 2002 Feb 01; 94(3):814-9. PubMed ID: 11857317
    [Abstract] [Full Text] [Related]

  • 14. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
    Eberle J, Fecker LF, Hossini AM, Wieder T, Daniel PT, Orfanos CE, Geilen CC.
    Oncogene; 2003 Dec 11; 22(57):9131-41. PubMed ID: 14668794
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes.
    Qin JZ, Chaturvedi V, Denning MF, Bacon P, Panella J, Choubey D, Nickoloff BJ.
    Oncogene; 2002 May 02; 21(19):2991-3002. PubMed ID: 12082529
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
    Müller KP, Mariani SM, Matiba B, Kyewski B, Krammer PH.
    Eur J Immunol; 1995 Oct 02; 25(10):2996-9. PubMed ID: 7589104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.